Intermittent Parathyroid Hormone after Prolonged Alendronate Treatment Induces Substantial New Bone Formation and Increases Bone Tissue Heterogeneity in Ovariectomized Rats

Postmenopausal osteoporosis is often treated with bisphosphonates (e.g. alendronate, ALN), but over-suppression of bone turnover by long-term bisphosphonate treatment may decrease bone tissue heterogeneity. Thus, alternate treatment strategies after long-term bisphosphonates are of great clinical in...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Bone Miner Res
Hlavní autoři: Altman-Singles, Allison R., Jeong, Yonghoon, Tseng, Wei-Ju, de Bakker, Chantal M. J., Zhao, Hongbo, Lott, Carina, Robberts, Juhanna, Qin, Ling, Han, Lin, Kim, Do-Gyoon, Liu, X. Sherry
Médium: Artigo
Jazyk:Inglês
Vydáno: 2017
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5550334/
https://ncbi.nlm.nih.gov/pubmed/28467646
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jbmr.3165
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky